Data search
Results for MligTC455_25860
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_25860 | 1063 | 22.16 | Mlig455_005876 | Neo: - Age: - Region-enriched R6: 2.187/0.00132 |
GLIPR2 | Mlig455_005876 {REF} {Length: 1599} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=84.1]} {Human: ENSG00000122694, GLIPR2, GLI pathogenesis related 2, [Score=106, Expect=1e-26]} {Mouse: ENSMUSG00000028480, Glipr2, GLI pathogenesis-related 2, [Score=108, Expect=8e-28]} {Dmel: FBgn0051482, CG31482, [RH, Score=101, Expect=1e-24]} {Celegans: WBGene00017055, D2062.1, [Score=73.6, Expect=6e-15]} {Smed: dd_Smed_v6_762_0_2, dd_Smed_v6_762_0_2, [RH, Score=147, Expect=5e-41]} {RNA1509_5334} {RNA1310_33115} {RNA815_15217.1} |
Cumulative graph for MligTC455_25860
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -1.054 | 4.793 | 0.42624 | 1.00000 | |
| RegionR2 | -1.444 | 4.793 | 0.03947 | 0.23079 | |
| RegionR3 | 0.1 | 4.793 | 0.84719 | 1.00000 | |
| RegionR4 | 0.828 | 4.793 | 0.20525 | 0.48696 | |
| RegionR5 | 0.426 | 4.793 | 0.39867 | 0.75539 | |
| RegionR6 | 2.187 | 4.793 | 0.00001 | 0.00132 | |
| RegionR7 | -1.069 | 4.793 | 0.12265 | 0.66080 | |
| RegionR8 | 0.025 | 4.793 | 0.97067 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -6.975 | 4.793 | 0.13200 | 0.86500 | |
| RegenerationR2 | -0.16 | 4.793 | 0.80671 | 0.99200 | |
| RegenerationR3 | -0.288 | 4.793 | 0.66034 | 0.93337 | |
| RegenerationR4 | -0.108 | 4.793 | 0.87206 | 1.00000 | |
| RegenerationR5 | 0.372 | 4.793 | 0.55843 | 0.89011 | |
| RegenerationR6 | -0.402 | 4.793 | 0.51017 | 0.81354 | |
| RegenerationBL | -0.678 | 4.793 | 0.29107 | 0.65319 | |
| RegenerationTP | 0.341 | 4.793 | 0.62441 | 0.97434 |
Genes with expression patterns similar to MligTC455_25860
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_25860 | 1063 | 22.16 | Mlig455_005876 | Neo: - Age: - Region-enriched R6: 2.187/0.00132 |
GLIPR2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_005876 {REF} {Length: 1599} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=84.1]} {Human: ENSG00000122694, GLIPR2, GLI pathogenesis related 2, [Score=106, Expect=1e-26]} {Mouse: ENSMUSG00000028480, Glipr2, GLI pathogenesis-related 2, [Score=108, Expect=8e-28]} {Dmel: FBgn0051482, CG31482, [RH, Score=101, Expect=1e-24]} {Celegans: WBGene00017055, D2062.1, [Score=73.6, Expect=6e-15]} {Smed: dd_Smed_v6_762_0_2, dd_Smed_v6_762_0_2, [RH, Score=147, Expect=5e-41]} {RNA1509_5334} {RNA1310_33115} {RNA815_15217.1} |
| 2. | MligTC455_25861 | 1578 | 32.88 | Mlig455_028673 | Neo: - Age: - Region-enriched R6: 2.474/0.00013 |
GLIPR2 | 4.553 | 0.895 | - | 0.871 | 0.949 | 0.881 | 0.957 | Mlig455_028673 {REF} {Length: 2280} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=85.0]} {Human: ENSG00000122694, GLIPR2, GLI pathogenesis related 2, [Score=106, Expect=2e-27]} {Mouse: ENSMUSG00000028480, Glipr2, GLI pathogenesis-related 2, [Score=108, Expect=2e-28]} {Dmel: FBgn0051482, CG31482, [Score=101, Expect=3e-25]} {Celegans: WBGene00017055, D2062.1, [Score=74.3, Expect=2e-15]} {Smed: dd_Smed_v6_762_0_2, dd_Smed_v6_762_0_2, [RH, Score=149, Expect=6e-43]} {RNA1509_26273, RNA1509_5334} {RNA1310_33115, RNA1509_26273} {RNA1509_26273, RNA815_15217.1} |
| 3. | MligTC455_25862 | 470 | 9.8 | Mlig455_028693 | Neo: - Age: - Region-enriched R6: 2.371/0.00723 |
GLIPR2 | 4.422 | 0.889 | 0.857 | - | 0.935 | 0.767 | 0.974 | Mlig455_028693 {REF} {Length: 1315} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=84.8]} {Human: ENSG00000122694, GLIPR2, GLI pathogenesis related 2, [Score=106, Expect=3e-27]} {Mouse: ENSMUSG00000028480, Glipr2, GLI pathogenesis-related 2, [Score=108, Expect=3e-28]} {Dmel: FBgn0051482, CG31482, [RH, Score=101, Expect=4e-25]} {Celegans: WBGene00017055, D2062.1, [Score=73.6, Expect=3e-15]} {Smed: dd_Smed_v6_762_0_2, dd_Smed_v6_762_0_2, [RH, Score=146, Expect=1e-41]} {RNA1509_5334} {RNA1310_33115} {RNA815_15217.1} |
| 4. | MligTC455_53964 | 191 | 3.98 | Mlig455_037522 | Neo: - Age: logFC(26M/2M)=0.823 Region-enriched R6: 3.461/0.00001 Regeneration-upregulated R5: 3.204 Regeneration-enriched R5: 3.204 |
3.5 | 0.848 | - | 0.807 | 0.886 | - | 0.959 | Mlig455_037522 {REF} {Length: 727} {Pfam: HYD1 signature containing ADP-ribosyltransferase [PF15633.8, score=50.4]} {RNA1509_6607} {RNA1310_59075} {RNA815_16430.3} | |
| 5. | MligTC455_30027 | 7836 | 163.26 | Mlig455_040228 | Neo: - Age: - Region-enriched R6: 1.458/0.00002 |
2.478 | 0.712 | - | 0.953 | - | 0.813 | - | Mlig455_040228 {REF} {Length: 1764} {Pfam: Thymosin beta-4 family [PF01290.22, score=71.5]} {Celegans: WBGene00006649, tth-1, Thymosin beta, [RH, Score=57.0, Expect=2e-11]} {Smed: dd_Smed_v6_17_0_1, dd_Smed_v6_17_0_1, [Score=76.6, Expect=3e-19]} {RNA1509_10258, RNA1509_36393, RNA1509_43737, RNA1509_48103, RNA1509_55021, RNA1509_6696, RNA1509_7344, RNA1509_7772} {RNA1310_18870, RNA1509_10258, RNA1509_36393, RNA1509_43737, RNA1509_48103, RNA1509_55021, RNA1509_6696, RNA1509_7344, RNA1509_7772} {RNA1509_10258, RNA1509_36393, RNA1509_43737, RNA1509_48103, RNA1509_55021, RNA1509_6696, RNA1509_7344, RNA1509_7772, RNA815_11078.1} | |
| 6. | MligTC455_50270 | 1381 | 28.78 | Mlig455_043519 | Neo: - Age: logFC(26M/2M)=-0.250 Regeneration-upregulated R5: 1.198 Regeneration-enriched R5: 1.198 |
PTK7 | 1.793 | - | - | - | 0.959 | 0.834 | - | Mlig455_043519 {REF} {Length: 5584} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=169.2]; Immunoglobulin domain [PF13927.8, score=142.9]; Immunoglobulin I-set domain [PF07679.18, score=110.6]; Protein kinase domain [PF00069.27, score=107.3]; Immunoglobulin domain [PF00047.27, score=91.5]; Immunoglobulin V-set domain [PF07686.19, score=76.1]; Immunoglobulin domain [PF13895.8, score=68.2]; Kinase-like [PF14531.8, score=19.3]; Transmembrane protein 51 [PF15345.8, score=19.0]} {Human: ENSG00000112655, PTK7, protein tyrosine kinase 7 (inactive), [Score=152, Expect=8e-37]} {Mouse: ENSMUSG00000023972, Ptk7, PTK7 protein tyrosine kinase 7, [Score=147, Expect=4e-35]} {Dmel: FBgn0003502, Btk29A, Btk family kinase at 29A, [Score=137, Expect=8e-34]} {Celegans: WBGene00000812, csk-1, Tyrosine-protein kinase csk-1, [Score=127, Expect=4e-30]} {Smed: dd_Smed_v6_6999_0_1, dd_Smed_v6_6999_0_1, [RH, Score=329, Expect=8e-94]} {RNA1509_41670, RNA1509_4351} {RNA1310_1753.1, RNA1509_41670} {RNA1509_41670, RNA815_731} |
| 7. | MligTC455_38561 | 120 | 2.51 | Mlig455_005612 | Neo: - Age: - |
CHRNA7 | 1.789 | - | - | - | - | 0.824 | 0.965 | Mlig455_005612 {REF} {Length: 1388} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=56.1]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=131, Expect=2e-33]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=131, Expect=2e-33]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=131, Expect=2e-33]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=130, Expect=5e-33]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=126, Expect=1e-31]; ENSG00000170175, CHRNB1, cholinergic receptor nicotinic beta 1 subunit, [Score=125, Expect=3e-31]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=125, Expect=3e-31]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=125, Expect=1e-31]; ENSG00000283946, CHRNB1, cholinergic receptor nicotinic beta 1 subunit, [Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=134, Expect=2e-34]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=129, Expect=8e-33]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=139, Expect=4e-36]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=148, Expect=1e-39]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=146, Expect=4e-39]} {RNA1310_19180} {RNA815_21410} |
| 8. | MligTC455_21476 | 726 | 15.12 | Mlig455_019236, Mlig455_035566 | Neo: - Age: logFC(26M/2M)=-0.433 |
SLC6A5, SLC6A9 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_019236 {REF} {Length: 3910} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=631.9]} {Human: ENSG00000196517, SLC6A9, solute carrier family 6 member 9, [RH, Score=513, Expect=4e-172]} {Mouse: ENSMUSG00000028542, Slc6a9, solute carrier family 6 (neurotransmitter transporter, glycine), member 9, [RH, Score=513, Expect=3e-173]} {Dmel: FBgn0034911, CG5549, [Score=486, Expect=3e-156]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=412, Expect=2e-134]} {Smed: dd_Smed_v6_5713_0_2, dd_Smed_v6_5713_0_2, [RH, Score=674, Expect=0.0]} {RNA1509_17386, RNA1509_4422, RNA1509_52580} {RNA1310_5588, RNA1509_17386, RNA1509_4422, RNA1509_52580} {RNA1509_17386, RNA1509_4422, RNA1509_52580, RNA815_1736.1} Mlig455_035566 {REF} {Length: 3334} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=455.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=389, Expect=2e-125]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=392, Expect=2e-126]} {Dmel: FBgn0034911, CG5549, [Score=339, Expect=2e-103]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=283, Expect=3e-87]} {Smed: dd_Smed_v6_5713_0_1, dd_Smed_v6_5713_0_1, [Score=517, Expect=5e-178]} {RNA1509_4422, RNA1509_48374} {RNA1310_5588, RNA1509_48374} {RNA1509_48374, RNA815_8455} |
| 9. | MligTC455_19866 | 483 | 10.05 | Mlig455_053987 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.360 Region-enriched R4: 2.346/0.01408 |
0.962 | - | - | - | 0.962 | - | - | Mlig455_053987 {REF} {Length: 3038} {RNA1509_43528} {RNA1310_35262.2, RNA1509_43528} {RNA1509_43528, RNA815_26662} | |
| 10. | MligTC455_26008 | 53 | 1.1 | Mlig455_023495 | Neo: - Age: logFC(26M/2M)=2.853 |
GTF2B | 0.955 | - | - | - | - | - | 0.955 | Mlig455_023495 {REF} {Length: 2399} {TRANSSPLICED} {Pfam: Transcription factor TFIIB repeat [PF00382.21, score=74.4]; F5/8 type C domain [PF00754.27, score=22.7]} {Human: ENSG00000137947, GTF2B, general transcription factor IIB, [Score=127, Expect=1e-33]} {Mouse: ENSMUSG00000028271, Gtf2b, general transcription factor IIB, [Score=127, Expect=7e-34]} {Dmel: FBgn0004915, TfIIB, Transcription factor IIB, [Score=134, Expect=2e-36]} {Celegans: WBGene00006648, ttb-1, Transcription initiation factor IIB, [Score=117, Expect=2e-30]} {Smed: dd_Smed_v6_2474_0_1, dd_Smed_v6_2474_0_1, [Score=99.4, Expect=8e-24]} {RNA1509_32364} {RNA1310_8246} {RNA815_13955} |
| 11. | MligTC455_32738 | 1811 | 37.74 | Mlig455_000115 | Neo: Neoblast, stringent Age: logFC(26M/2M)=0.432 Region-enriched R5: 1.692/0.00003 |
RRM1 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_000115 {REF} {Length: 3287} {Pfam: Ribonucleotide reductase, barrel domain [PF02867.17, score=612.4]; Ribonucleotide reductase, all-alpha domain [PF00317.23, score=78.9]; ATP cone domain [PF03477.18, score=63.3]} {Human: ENSG00000167325, RRM1, ribonucleotide reductase catalytic subunit M1, [RH, Score=1181, Expect=0.0]} {Mouse: ENSMUSG00000030978, Rrm1, ribonucleotide reductase M1, [RH, Score=1187, Expect=0.0]} {Dmel: FBgn0011703, RnrL, Ribonucleoside diphosphate reductase large subunit, [RH, Score=1140, Expect=0.0]} {Celegans: WBGene00004391, rnr-1, Ribonucleoside-diphosphate reductase large subunit, [RH, Score=1119, Expect=0.0]} {Smed: dd_Smed_v6_1651_0_1, dd_Smed_v6_1651_0_1, [RH, Score=1077, Expect=0.0]} {RNA1509_12563, RNA1509_31863} {RNA1310_3739.1, RNA1509_12563, RNA1509_31863} {RNA1509_12563, RNA1509_31863, RNA815_1323} |
| 12. | MligTC455_18580 | 849 | 17.69 | Mlig455_028456 | Neo: - Age: logFC(26M/2M)=0.546 |
MIOX | 0.952 | - | - | - | 0.952 | - | - | Mlig455_028456 {REF} {Length: 1966} {Pfam: Myo-inositol oxygenase [PF05153.17, score=358.9]; HD domain [PF01966.24, score=21.5]} {Human: ENSG00000100253, MIOX, myo-inositol oxygenase, [RH, Score=320, Expect=7e-110]} {Mouse: ENSMUSG00000022613, Miox, myo-inositol oxygenase, [RH, Score=323, Expect=3e-111]} {Dmel: FBgn0036262, CG6910, [RH, Score=317, Expect=2e-108]} {Celegans: WBGene00016920, C54E4.5, [RH, Score=291, Expect=9e-99]} {Smed: dd_Smed_v6_9182_0_1, dd_Smed_v6_9182_0_1, [RH, Score=332, Expect=9e-115]} {RNA1509_27562, RNA1509_40490, RNA1509_42386, RNA1509_4366, RNA1509_55293, RNA1509_57124} {RNA1310_17520, RNA1509_27562, RNA1509_40490, RNA1509_42386, RNA1509_4366, RNA1509_55293, RNA1509_57124} {RNA1509_27562, RNA1509_40490, RNA1509_42386, RNA1509_4366, RNA1509_55293, RNA1509_57124, RNA815_6520.1} |
| 13. | MligTC455_32700 | 535 | 11.16 | Mlig455_038216, Mlig455_038291 | Neo: Irradiation Age: Up-Down-Down |
FGFR3 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_038216 {REF} {Length: 5847} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=270.7]; Protein kinase domain [PF00069.27, score=129.9]; Immunoglobulin domain [PF13927.8, score=37.1]; Immunoglobulin domain [PF00047.27, score=33.1]; Immunoglobulin domain [PF13895.8, score=29.4]; Immunoglobulin V-set domain [PF07686.19, score=25.2]; Fungal protein kinase [PF17667.3, score=18.7]} {Human: ENSG00000068078, FGFR3, fibroblast growth factor receptor 3, [RH, Score=224, Expect=6e-62]; ENSG00000077782, FGFR1, fibroblast growth factor receptor 1, [RH, Score=220, Expect=3e-60]; ENSG00000066468, FGFR2, fibroblast growth factor receptor 2, [RH, Score=214, Expect=3e-58]} {Mouse: ENSMUSG00000031565, Fgfr1, fibroblast growth factor receptor 1, [RH, Score=220, Expect=2e-60]; ENSMUSG00000054252, Fgfr3, fibroblast growth factor receptor 3, [RH, Score=219, Expect=7e-60]; ENSMUSG00000030849, Fgfr2, fibroblast growth factor receptor 2, [RH, Score=214, Expect=4e-59]} {Dmel: FBgn0010389, htl, heartless, [RH, Score=223, Expect=2e-61]} {Celegans: WBGene00001184, egl-15, Myoblast growth factor receptor egl-15, [RH, Score=223, Expect=2e-60]} {Smed: dd_Smed_v6_12998_0_1, dd_Smed_v6_12998_0_1, [RH, Score=223, Expect=3e-61]} {RNA1509_25243} {RNA1310_14119} {RNA815_2456.1} Mlig455_038291 {REF} {Length: 4686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=270.7]; Protein kinase domain [PF00069.27, score=128.7]; Immunoglobulin domain [PF13927.8, score=34.4]; Immunoglobulin domain [PF00047.27, score=30.3]; Immunoglobulin domain [PF13895.8, score=27.9]; Immunoglobulin V-set domain [PF07686.19, score=23.2]; Fungal protein kinase [PF17667.3, score=18.7]} {Human: ENSG00000068078, FGFR3, fibroblast growth factor receptor 3, [RH, Score=221, Expect=8e-61]; ENSG00000077782, FGFR1, fibroblast growth factor receptor 1, [RH, Score=217, Expect=4e-59]; ENSG00000066468, FGFR2, fibroblast growth factor receptor 2, [RH, Score=211, Expect=4e-57]} {Mouse: ENSMUSG00000054252, Fgfr3, fibroblast growth factor receptor 3, [RH, Score=217, Expect=5e-59]; ENSMUSG00000031565, Fgfr1, fibroblast growth factor receptor 1, [RH, Score=217, Expect=2e-59]; ENSMUSG00000030849, Fgfr2, fibroblast growth factor receptor 2, [RH, Score=211, Expect=5e-58]} {Dmel: FBgn0285896, btl, breathless, [RH, Score=221, Expect=2e-59]} {Celegans: WBGene00001184, egl-15, Myoblast growth factor receptor egl-15, [RH, Score=221, Expect=1e-59]} {Smed: dd_Smed_v6_12998_0_1, dd_Smed_v6_12998_0_1, [RH, Score=220, Expect=3e-60]} {RNA1509_25243} {RNA1310_14119} {RNA815_2456.1} |
| 14. | MligTC455_39419 | 9898 | 206.2 | Mlig455_027496 | Neo: - Age: - Region-specific R6: 1.797 Region-enriched R6: 1.649/0.00000 |
VIL1 | 0.952 | 0.952 | - | - | - | - | - | Mlig455_027496 {REF} {Length: 2220} {Pfam: Gelsolin repeat [PF00626.24, score=122.5]} {Human: ENSG00000127831, VIL1, villin 1, [Score=195, Expect=4e-58]; ENSG00000135407, AVIL, advillin, [Score=192, Expect=4e-54]} {Mouse: ENSMUSG00000026879, Gsn, gelsolin, [Score=192, Expect=1e-55]; ENSMUSG00000026175, Vil1, villin 1, [Score=191, Expect=4e-54]; ENSMUSG00000025432, Avil, advillin, [Score=186, Expect=3e-52]} {Dmel: FBgn0010225, Gel, Gelsolin, [Score=201, Expect=4e-58]} {Celegans: WBGene00010593, gsnl-1, Gelsolin-like protein 1, [Score=173, Expect=1e-49]} {Smed: dd_Smed_v6_1673_0_1, dd_Smed_v6_1673_0_1, [RH, Score=418, Expect=2e-146]} {RNA1509_1476, RNA1509_4857} {RNA1310_17869, RNA1509_1476, RNA1509_4857} {RNA1509_1476, RNA1509_4857, RNA815_6372} |
| 15. | MligTC455_47960 | 579 | 12.07 | Mlig455_062134 | Neo: - Age: Up-Down-Up |
XYLT1 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_062134 {REF} {Length: 3687} {TRANSSPLICED} {Pfam: Core-2/I-Branching enzyme [PF02485.23, score=107.8]; Xylosyltransferase C terminal [PF12529.10, score=30.4]} {Human: ENSG00000285395, XYLT1, xylosyltransferase 1, [RH, Score=320, Expect=3e-94]; ENSG00000103489, XYLT1, xylosyltransferase 1, [RH, Score=320, Expect=3e-94]; ENSG00000015532, XYLT2, xylosyltransferase 2, [RH, Score=312, Expect=5e-92]} {Mouse: ENSMUSG00000030657, Xylt1, xylosyltransferase 1, [RH, Score=322, Expect=3e-95]; ENSMUSG00000020868, Xylt2, xylosyltransferase II, [RH, Score=310, Expect=3e-91]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [RH, Score=321, Expect=1e-95]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [RH, Score=278, Expect=1e-80]} {Smed: dd_Smed_v6_11313_0_1, dd_Smed_v6_11313_0_1, [RH, Score=250, Expect=4e-71]} {RNA1509_14760} {RNA1310_3804.1, RNA1509_14760} {RNA1509_14760, RNA815_13657.1} |
Berezikov Lab - 2020-2021 © ERIBA